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Indirect evidence suggests that improved insulin
sensitivity may contribute to improved lifespan of
mice in which aging has been slowed by mutations,
drugs, or dietary means, even in stocks of mice that
do not show signs of late-life diabetes. Peripheral
responses to insulin can be augmented by overex-
pression of Syntaxin 4 (Syn4), a plasma-membrane-
localized SNARE protein. We show here that Syn4
transgenic (Tg) mice with high level expression of
Syn4 had a significant extension of lifespan (33%
increase in median) and showed increased periph-
eral insulin sensitivity, even at ages where controls
exhibited age-related insulin resistance. Moreover,
skeletal muscle GLUT4 and islet insulin granule
exocytosis processes were fully protected in Syn4
Tg mice challenged with a high-fat diet. Hence,
high-level expressing Syn4 Tg mice may exert better
glycemic control, which slows multiple aspects of
aging and extends lifespan, even in non-diabetic
mice.
INTRODUCTION
The prevalence of type 2 diabetes mellitus (T2D) increases sub-
stantially with age. Both aging and T2D are accompanied by
deleterious physiological changes, such as the development of
insulin resistance, diminished glucose tolerance, fat accumula-
tion, and loss of muscle mass (Biddinger and Kahn, 2006; Saltiel
and Kahn, 2001). Despite a strong correlation between aging and
T2D, the molecular events linking aging and T2D are unknown.
There are many mouse models in which slow aging and long
life are associated with higher insulin sensitivity. This includes
GHRKO, Snell and Ames dwarf, calorie restriction, and the
crowded litter mice (Sadagurski et al., 2014). Further, the
GHRKO and pituitary dwarf mutations slow many aspects of ag-
ing. This has led to a model in which excellent, and preserved,
insulin sensitivity is postulated as a key causal factor (Bartke
et al., 2003) in extended longevity in many kinds of experimentalCell Memice. Fat-specific deletion of insulin receptor (IR) also leads to
longevity in mice, as does deletion of IR or IRS in some brain re-
gions (Blu¨her et al., 2003; Taguchi et al., 2007). This too hints at
links between insulin sensitivity and whole animal aging.
One clue from studies of centenarians demonstrates that this
population displays increased peripheral insulin sensitivity and
reduced circulating insulin concentrations and has reduced
adipose tissue mass when compared to younger generations
(Barbieri et al., 2003; Biddinger and Kahn, 2006; Klo¨ting and
Blu¨her, 2005; Paolisso et al., 1996; Rozing et al., 2010; Wijsman
et al., 2011), suggesting that insulin signaling and/or synthesis
genes may link diabetes and aging. Moreover, people with a
mutation in GHR were protected against cancer and diabetes
(Guevara-Aguirre et al., 2011). Several proteins thought to play
a role in regulation of aging, including insulin like growth factor
(IGF-1), mammalian target of rapamycin (mTOR), and mamma-
lian homolog of the Silent information regulator 2 (SIRT1), have
also been implicated in the control of glucose homeostasis and
diabetes pathogenesis. In humans, genetic variation causing
reduced insulin/IGF-1 signaling is associated with extended
longevity (van Heemst et al., 2005). Similarly, IGF-1-receptor-
deficient knockout mice as well as a model of reduced local
IGF activity (pregnancy-associated plasma protein-A knockout
mice) show increased longevity (Conover et al., 2008; Xu et al.,
2014). Depletion of S6K1 (a downstream target protein of
mTOR) in mice increased lifespan and maintained insulin sensi-
tivity (Selman et al., 2009; Um et al., 2004). SIRT1 overexpression
in brain-specific transgenic mice was recently shown to increase
lifespan by 11% (Satoh et al., 2013). However, while increased
SIRT1 selectively in pancreatic b cells of transgenic mice
enhanced glucose-stimulated insulin secretion and improved
glucose tolerance at 8 months of age, these benefits were lost
by 18 months of age (Moynihan et al., 2005; Ramsey et al.,
2008). Reduced insulin sensitivity has also, in some circum-
stances, been associated with lifespan extension in mice,
including that mediated by rapamycin (Harper et al., 2005; Miller
et al., 2014). Hence, whether improved insulin secretion and/or
increased insulin sensitivity are sufficient to promote extended
lifespan remains in question.
Syn4 is a SNARE protein that functions at the distal end of the
insulin signaling cascade to promote clearance of excess
glucose from the blood. Syn4 is similarly required for pancreatic
b cell insulin secretion in response to elevated blood glucose.tabolism 22, 499–507, September 1, 2015 ª2015 Elsevier Inc. 499
Therefore, changes in Syn4 protein levels affect two of the most
important processes required to regulate blood glucose levels
and maintain glucose homeostasis. Importantly, Syn4 protein
levels are significantly reduced in human T2D islets (Oh et al.,
2014), as are Syn4 mRNA levels in ob/ob (Keller et al., 2008)
and STZ-diabetic mice (Yechoor et al., 2002); mice deficient in
Syn4 exhibit insulin resistance and dysfunctional insulin secre-
tion (Spurlin et al., 2004; Spurlin and Thurmond, 2006; Yang
et al., 2001). Thus, deficiency of Syn4 may be associated with
an increased susceptibility of the aged or obese to develop
T2D. In the current study, we report the existence of a relation-
ship between Syn4 abundance, healthspan and aging, pertinent
to insulin-secreting and insulin-responsive cellular mechanisms
affecting glucose homeostatic changes.
RESULTS
Relationship between Syn4 Abundance and Aging
Given the current queries into the relationship between longevity
and glucose homeostasis, we investigated abundances of
exocytosis proteins in pancreas lysates of differentially aged
mice and found Syn4 to be selectively attenuated in a manner
inversely related to that of the known aging-induced p-mTOR
(Figure 1A). No differences in pancreatic abundances of Syn4-
based SNARE partners VAMP2, SNAP23, or Munc18c were
observed with aging (Figure S1). This observation led to a longi-
tudinal study of Syn4 transgenic (Syn4 Tg) mice. The Syn4 Tg
mice express higher levels of Syn4 protein specifically in the
pancreas, skeletal muscle, and adipose tissues and exhibit
enhanced insulin sensitivity and accelerated glucose clearance
(Spurlin et al., 2004) and have the capacity to release 30%
more insulin per islet while retaining biphasic kinetics (Spurlin
and Thurmond, 2006). Remarkably, the Syn4 Tg mice lived
33% longer than wild-type control (Con) littermates (p <
0.001), with similar effects in male and female mice (Figures
1B–1D). In this regard, significant upregulation of Syn4 yields life-
span extension similar to that produced by caloric restriction,
and more than rapamycin or acarbose treatments (Harrison
et al., 2014; Miller et al., 2014). The overall lifespan of the control
(Con) micewas somewhat shorter than expected for this strain of
mice (Ikeno et al., 2005). Aging-related gene products such as
SIRT1 or mTOR were unchanged in pancreata of Syn4 Tg mice
relative to littermate controls (Figure 1E), despite the continued
expression of the transgene in the aged Tg mice (Figure 1F;
2.1-fold more Syn4 protein compared with Con, n = 4). While
the amount of phosphorylated FoxO1 (Ser256) was also un-
changed in Syn4 Tg pancreata, total FoxO1 levels were 2-fold
greater, thus decreasing the relative level of phosphorylated
FoxO1 (Figure 1E). Given the trend for reduced Syn4 protein in
aged Con mouse muscle (Figure S2) and the persistence of
elevated Syn4 levels in the muscle of the aged Tg mice, (Fig-
ure 1F; 3.3-fold more Syn4 protein compared with Con, n = 4),
we used microarray to assess potential relative changes in skel-
etal muscle genes. In those genes with absolute fold change
R1.2, Ingenuity pathway analysis revealed 12 pathways that
were significantly changed (Table S1). Pathways identified
included AMPK signaling, leptin signaling, cAMP, and nNOS sig-
naling in skeletal muscle. Quantitative real-time PCR was used
to confirm a set of seven differentially expressed genes from500 Cell Metabolism 22, 499–507, September 1, 2015 ª2015 Elseviethese pathways; of these, four were statistically significant
(Table S2). These data collectively suggested the existence
of a specific inverse relationship between aging and Syn4
abundance.
Glucose Homeostatic Mechanisms in Long-Lived Syn4
Tg Mice
Comparing the insulin tolerance tests of 25-month-old mice with
the response of this strain at 4–6 months of age (Spurlin et al.,
2004), the Syn4 Tg mice showed enhanced insulin sensitivity
(Figure 2A). Increased insulin sensitivity was particularly notable
in Syn4 Tg males (Figure 2B), since aged C57BL/6 males are
characteristically insulin resistant (Lee et al., 2010). Consistent
with this, aged Syn4 Tg mice were significantly more glucose
tolerant than controls (Figures 2C and 2D). Syn4 upregulation
was not associated with dwarfism and occurred independent
of caloric restriction, as evidenced by body weight and food
intake measures (Figures 2E and 2F). Metabolic caging studies
showed no significant differences between 12-month-old Con
and Tg mice for respiratory quotient (RQ) and movement/activity
level (Figures 2G and 2H). Although body fat content was also
similar (Figure 2I), serum triglycerides were slightly but signifi-
cantly diminished in the Syn4 Tg mice (Figure 2J). These data
suggest that increasing the capacity for exocytosis in skeletal
muscle is sufficient to protect against age-induced insulin re-
sistance, and by extrapolation, it could be speculated that an
age-generated deficiency in exocytosis might underlie the devel-
opment of insulin resistance with aging.
Glucose tolerance and homeostasis is substantially affected
by functional b cell mass. Serum insulin content in fasted Syn4
Tg versusConmicewas reduced at 18months of age (Figure 3A),
rising in both strains by age 24 months (p = 0.0275 by two-way
ANOVA). Following a glucose injection, 6-month-old Syn4 Tg
mice exhibited a left-shifted insulin response in vivo, showing a
peak in serum insulin content by 5 min, as opposed to that
seen in control mice (Figure 3B); serum glucagon levels were
not different between Syn4 Tg and Con mice under fasted or
glucose-stimulated conditions (Figure 3C). The rapid serum insu-
lin response of the Syn4 Tg mice is consistent with an amplified
glucose-stimulated insulin secretory response from their islets
ex vivo (Figure 3D) and was not affiliated with changes in islet in-
sulin content or distribution of b and a cells within the islets (Fig-
ures 3E and 3F). The percentage of b cell area remained similar
between 18-month-old Syn4 Tg and Con mice (Figure 3G),
although both were elevated by 2-fold relative to that reported
for 6-month-oldSyn4TgandCon littermatemice (Ohet al., 2014).
These data suggest that islet function was increased in the Syn4
Tg mice, independent of insulin content and islet morphometry.
Syn4-Induced Resistance to Obesity-Induced
Dysfunction
The onset of pre/type 2 diabetes with aging is associated with
increasing adiposity/obesity in humans. Activities of proteins
associated with lifespan and longevity, such as FoxO3, FoxO1,
mTOR, IRS1, AMPK, and SIRT1, reportedly change with high-
fat diet (HFD) (Battiprolu et al., 2012; Chalkiadaki and Guarente,
2012; Rivas et al., 2009). To assess whether Syn4 Tg and Con
mice differ in responses to dietary fat, mice were fed a diabeto-
genic 60% HFD or regular chow diet (RD) for 10 weeks. Bothr Inc.
Figure 1. Syn4 Abundance and Aging
(A) Protein levels in pancreata of 4- and 18-month-old C57BL/6J mice: Syn4 relative to tubulin (loading control), phosphorylated mTOR relative to total mTOR.
Data represent the mean ± SE of five sets of pancreata. *p < 0.05.
(B–D) Proportion of all mice surviving, for males (12 Con and 11 Syn4 Tg), females (7 Con and 6 Syn4 Tg), versus both sexes pooled (19 Con and 17 Syn4 Tg).
(E) Abundance/activation of proteins associated with aging in three paired sets of pancreata from male mice: phosphorylated/total mTOR, total SIRT1, and
phosphorylated/total FoxO1 (pSer256).
(F) Levels of transgene expression in aged male pancreatic and skeletal muscle (Sk. Muscle) mouse lysates, representative of n = 4/group.Syn4 Tg and Con mice showed equivalently increased body
weight on either RD or HFD (Figure 4A). The relative fat pad
weights of HFD-fed Tg and Con mice were similarly elevated
above that of RD-fed mice (0.022 g/g BW for RD-Con and
0.024 RD–Tg, n = 4/group) (Figure 4B). Weights of other tissues,
including liver, were similar between HFD-fed Tg and Con miceCell Me(Figure 4B). This is consistent with similarities in hepatic glucose
uptake function and insulin action in Syn4 Tg andConmice in hy-
perinsulinemic-euglycemic clamp analyses (Spurlin et al., 2004).
Food intake was similar between Con and Tg mice on either RD
or HFD (Figure 4C). Despite the obesity, HFD-fed Syn4 Tg mice
retained the normal 2-fold increase in insulin-stimulated GLUT4tabolism 22, 499–507, September 1, 2015 ª2015 Elsevier Inc. 501
Figure 2. Improved Insulin and Glucose Tolerance in Aged Syn4 Tg Mice
(A and B) Insulin tolerance tests were assessed in 25-month-old mice with both sexes combined (A) or males alone (B); *p < 0.05 ([A], 8 Con and 12 Tg mice; [B],
6 Con and 8 Tg mice).
(C and D) Glucose tolerance tests were performed in 24-month-old mice, both with sexes combined (C), and in males alone (D) with bar graphs denoting area
under the curve (AUC); *p < 0.05 ([C], 12 Con and 16 Tg; [D], 8 Con and 9 Tg mice).
(E–H) Metabolic caging studies, wherein data represent the average ± SE for four to nine pairs of 12-month-old male and female mice: body weights (E), food
intake (F), RQ (G), and physical activity (H).
(I) DEXA scanning quantified body fat in four pairs of 8-month-old male mice. Serum triglycerides (18-month-old 7 Con and 7 Tg, sexes combined) (J); *p < 0.05.
BW, body weight.
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Figure 3. Syn4 Tg Mice Show Robust Islet Function
(A) Fasting serum insulin content in aged mice. Data represent the average ± SE (18 months: 7 Con, 6 Tg mice; 24 months: 5 Con and 5 Tg).
(B and C) Serum insulin and glucagon contents during glucose tolerance testing in 6-month-old male mice. Data represent the average ± SE of 6–8 mice per
group; *p < 0.05 versus Con at same time point. Glucagon in serum from mice fasted (0) and after glucose stimulation (10 min).
(D and E) Static insulin release from mouse islets ex vivo and insulin content therefrom (n = 3 to 4 islet batches from 6-month-old mice); *p < 0.05.
(F and G) Islet cell distributions (red, glucagon stained a cell; green, insulin stained b cell) and percentage of b cell area in 18-month-oldmouse islets (n = 3/group).accumulation in skeletal muscle t-tubules/sarcolemma reported
for similarly aged chow-fed control mice (dashed line) (Spurlin
et al., 2004); by contrast, HFD-fed Con mice failed to respond
to insulin (Figure 4D).
Within just 2 weeks on the HFD, fasting serum insulin levels of
the Syn4 Tgmice were significantly higher than those of HFD-fed
Con mice (Figure 4E), elevated relative to those reported for
similarly aged chow-fed mice (Spurlin et al., 2004). Islets from
HFD-fed Syn4 Tg mice also retained the 16-fold increase in
glucose-stimulated insulin secretion seen in the RD-Con mice
(dashed line), while the response of the Con-HFD islets ex vivo
fell by 50% (Figure 4F). In terms of islet insulin content, HFD-
fed Syn4 Tg mice showed an increase relative to RD-fed Tg
mice, whereas HFD-Con and RD-Con showed no differences
(Figure 4G). b cell area was similar between the HFD-Con and
HFD-Syn4 Tg mice (Figure 4H), with both being increased by
nearly 2-fold relative to age-matched RD-fed mice (RD-Con
and RD-Tg, both 0.7% in Oh et al. [2014]), and rising to levels
otherwise seen in the aged mice of Figure 3G. These data sug-
gest that Syn4 enrichment preserves exocytotic activities in skel-
etal muscle and islet b cells with aging and with obesity.
DISCUSSION
These data demonstrate a previously unrecognized role for an
exocytosis factor in promoting the extension of lifespan. InsightCell Meinto how Syn4 promotes healthspan stems from data showing
that Syn4 Tg mice exhibit accelerated and enhanced capacity
for glucose uptake and insulin release, as well as faster ‘‘re-
equilibration’’ of glycemia and insulinemia following a glucose
challenge. When challenged with HFD-induced obesity, skel-
etal muscle GLUT4 and islet insulin granule exocytosis pro-
cesses were fully protected in the Syn4 Tg mice, matching
levels equivalent to those of chow-fed Con mice; HFD-Con
mice showed significant lapses in both exocytotic processes.
Intriguingly, the Migration inhibition factor knockout mouse
(MIF KO) showed a 15% extension of lifespan (Harper et al.,
2010), and MIF deficiency is linked to protection from age-
related insulin resistance (Verschuren et al., 2009) and from
inflammation in islets associated with type 1 and type 2 dia-
betes (Stojanovic et al., 2012; Stosic-Grujicic et al., 2008).
Despite the similarities with MIF deficiency in terms of lifespan
extension and improvements in insulin secretion and insulin ac-
tion, the Syn4-enriched Tg mice did not exhibit differences in
inflammation, as assessed via serum levels of inflammatory
factors TNFa or IL-6, with aging or under HFD-induced inflam-
matory conditions (Tables S3 and S4). However, finding that
the capacity of islets of HFD-fed Syn4 Tg mice to increase in-
sulin content, without increasing b cell mass, suggests that this
exocytotic protein may play an otherwise unappreciated role in
insulin biosynthesis. The increased capacity to synthesize and
secrete insulin may be unrelated to the increased lifespan oftabolism 22, 499–507, September 1, 2015 ª2015 Elsevier Inc. 503
Figure 4. Protection of Skeletal Muscle and
Islet Function in High-Fat-Fed Syn4 Tg
Male Mice
(A–C) Body weight (A), tissue weights (B), and food
intake (C) in control (Con) and Syn4 Tg mice ([A]
and [C], n = 8–12 per group; [B], n = 4 to 5 per
group).
(D) Skeletal muscle GLUT4 accumulated at the
cell surface (stimulation index = insulin/basal levels
of GLUT4 at cell surface). Data represent the
average ± SE of four matched sets of mice/group;
*p < 0.05). Dashed line, average RD-Con mice.
(E) Fasting serum insulin content during the HFD
study (n = 6 mice/group; *p < 0.05).
(F) Glucose-stimulated insulin release (stimulation
index = glucose stimulated/basal) of islets from
mice fed HFD for 10 weeks (n = 3 mice/group).
Dashed line, average RD-Con mice; p = 0.07, RD-
Con versus HFD-Con.
(G) Islet insulin content after 10 weeks on HFD;
data represent the average ± SE of six mice/group;
*p < 0.05 versus Tg fed the RD.
(H) b cell area for 6-month-old mice fed HFD for 10
wks; n = 3 pancreata/group. Body weight, BW.the Syn4 Tg mouse; however, since the long-lived GHRKO
mouse has marked reductions in these aspects (Bartke and
Westbrook, 2012; Coschigano et al., 2003; Junnila et al.,
2013; List et al., 2011).
Microarray analysis of muscle from Syn4 Tg and Con mice
pointed to changes in pathways of leptin and AMPK signaling,
as well as cAMP and nNOS signaling in skeletal muscle, and
components of these pathways are affiliated with lifespan
extension (Tables S1 and S2). At the protein level, relative phos-
phorylated FoxO1 in pancreata from the Syn4 Tg mice was
reduced, consistent with the association of health and longevity
with decreased pFoxO1 in liver (Laurent et al., 2008; Tomobe
et al., 2013). Relatedly, pFoxO1 is elevated in cardiac tissue
of diabetic and HFD-fed mice (Battiprolu et al., 2012). Our
findings of ‘‘normal’’ insulin sensitivity in aged Syn4 Tg mice pro-
vides a clue suggestive of increased ‘‘healthspan’’ in addition to
longevity, although more evidence will be required to demon-
strate broad improvement in late-life health in these mice. Pres-
ervation of insulin sensitivity into old age may reflect enhanced
responsiveness by the skeletal muscle to the insulin signal, itself
a consequence of more rapid GLUT4 vesicle accumulation at the
t-tubule/sarcolemmal membranes, leading to faster clearance of
circulating glucose. This is consistent with reports citing hyper-
glycemia as damaging to cells and leading to shorter lifespan504 Cell Metabolism 22, 499–507, September 1, 2015 ª2015 Elsevier Inc.(Fitzenberger et al., 2013; Yang et al.,
2005). Additionally, this enhanced muscle
response to insulin was maintained in
obese Syn4 Tg mice. The decreased
serum triglyceride content of the aged
Syn4 Tg mice was unexpected, particu-
larly given that 3- to 6-month-old Syn4
Tg mice or HFD-fed Syn4 Tg mice failed
to show differences from paired Con
mice in triglyceride contents (Spurlin
et al., 2004). While Syn4 Tg mice at 3 to4 months of age also show normal hepatic insulin signaling
and glucose uptake, and normal adipocyte glucose uptake and
glycolytic functions (Spurlin et al., 2004), it remains possible
that crosstalk from the tissues expressing the transgene in this
model (pancreas, skeletal muscle, and fat) to the liver, or func-
tions directly in the fat, affect serum triglyceride levels with
increasing age.
Syn4 may also act through changes in NADmetabolism in one
or more of these tissues expressing the transgene. Increased
NAD is associated with increased healthspan and longevity (re-
viewed in Verdin, 2014), dependent upon SIRT1 (Mitchell et al.,
2014), and NAD-mediated PARP inhibition in C. elegans (Mou-
chiroud et al., 2013). However, SIRT1 protein and transcript
levels of all sirtuins detected were normal, and although PARP
could not be detected in the islet by microarray methods, it is
their activity that NAD influences acutely, and hence may be
impacted somehow by increased Syn4. Another possibility is
that Syn4 indirectly impacts IR function in aging via its ability to
bind and potentially chaperone translation of the IR substrate
protein, Munc18c (Jewell et al., 2011; Spurlin et al., 2004; Yang
et al., 2001), and that this alters IR signaling in aging at a post-
transcriptional level to extend lifespan. The current report is
also accompanied by a second site replicate cohort conducted
at the University of Michigan, which revealed potential ‘‘site
effects’’ and transgene dosage effects upon lifespan (Thurmond
et al., 2015). Hence, efforts to sort out the potential roles for Syn4
in aging will require tissue-specific Syn4 transgenic models to
clarify the individual tissue-related beneficial contributions to
the longevity phenotype. For example, would a b-cell-specific
Syn4 transgenic mouse show improved peripheral insulin sensi-
tivity? Indeed, reports from other models suggest that improved
b cell function could be sufficient to control peripheral insulin
resistance (Buchanan et al., 2002; Li et al., 2004). Alternatively,
a skeletal-muscle-specific Syn4 mouse protected from age-
induced insulin resistance could obviate the need for compen-
satory elevation of b cell insulin release. Examination of such
models may otherwise reveal that it is the simultaneous enrich-
ment of Syn4 in the b cell and skeletal muscle that confers the
extended healthspan and longevity phenotype, which would
be important going forward with strategies to target Syn4
expression and activation.
EXPERIMENTAL PROCEDURES
Animals
All animal studies were approved by the Indiana University School of Medicine
Institutional Animal Care and Use Committee (IACUC). The rat Syntaxin 4
cDNA inserted into the pUC-Combi targeting vector (Schultze et al., 1996)
was used to generate heterozygous transgenic mice on the C57BL/6J
strain background as described (Spurlin et al., 2004); wild-type littermates
served as controls. Detailed methods are available in the Supplemental
Materials.
Metabolic Studies
Mice were fasted for IPGTT (2 g glucose/kg BW) and ITT (0.75 U/kg BW)
studies, as described (Spurlin et al., 2004). Indirect calorimetric measurement
was performed using a TSE systems LabMaster Metabolism Research Plat-
form. Body fat percentage was measured by DEXA. Serum analytes were
quantified by the Hormone Assay and Analytical Services Core at Vanderbilt
University.
GLUT4 Translocation
Fasted male mice were injected intraperitoneally with 21 U/kg BW Humulin or
vehicle (saline) and sacrificed for removal of the hindquarter muscles for
homogenization and subsequent differential centrifugation and detection of
GLUT4 as described (Zhou et al., 1998).
Islet Isolation and Immunofluorescence, and Tissue
Immunohistochemistry and Immunoblotting
Mouse islets were isolated as described (Spurlin et al., 2004). Islet morphom-
etry was used to determine b cell area as described (Wang et al., 2011); data
shown represent three sections per pancreata, using three pancreata from
each group. Pancreatic and skeletal muscle hindlimb lysate proteins were
resolved for immunoblot detection as described (Oh et al., 2014).
Microarray
Hindlimb skeletal muscle was dissected from 5-month-old Con and Syn4
Tg mice for RNA isolation. RNA was labeled using the Ambion WT expression
kit and hybridized to Affymetrix Mouse Gene 1.0 ST arrays. Differentially
expressed genes were analyzed using the 2014 Fall Release of QIAGEN’s
Ingenuity Pathway Analysis (IPA, QIAGEN Redwood City, http://www.
ingenuity.com). Pathway, Functional and Upstream analysis were performed
using Genes that had absolute fold changes R1.2. Data for the microarrays
are deposited in NCBI’s GEO with series accession number GEO: GSE63780.
Statistical Analysis
All values are presented as means ± SE. Differences were analyzed by
Student’s t test or two-way ANOVA.Cell MeSUPPLEMENTAL INFORMATION
Supplemental Information includes two figures, four tables, and Supplemental
Experimental Procedures and can be found with this article online at http://dx.
doi.org/10.1016/j.cmet.2015.07.023.
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